Comparative Evaluation of Branded and Generic Medicines - Ranitidine & Metformin HCl
Journal: International Research Journal of Pharmacy and Medical Sciences (IRJPMS) (Vol.1, No. 4)Publication Date: 2018-07-10
Authors : Srinivas Nandyala P. SS. Prasanna Kumar A. Ravi Kumar S. Sravanya Sai Lakshmi P. Sai Supraja D. Tejasri SK. Adil;
Page : 24-28
Keywords : Branded Drug; Generic Drug; Drug Codes; Ranitidine; Metformin HCl; H2 Receptor Antagonist; Anti-Diabetic.;
Abstract
Ranitidine is H2 receptor antagonist used to treat Duodenal ulcers, Metformin HCl is Biguanide Antihyperglycemic agent used used for treating non-Insulin dependent Diabetes Mellitus (NIDDM) and as anti-diabetic used for the treatment of Type-2 Diabetes Milletus. The present study was to compare and evaluate the Quality and Price of Ranitidine and Metformin HCl Branded and Generic medicines. The selected Branded and Generic tablets are coded as C1, C2, C3, C4. Each tablets were evaluated for evaluation parameters such as Weight variation, Hardness, Friability, Disintegration, Assay, in-vitro Dissolution. From the results based on the Evaluation tests of Tablets and invitro dissolution rate studies, the Branded Medicines showed better Drug release and followed First order kinetics of Drug Release.
Other Latest Articles
- Review of the International Conference “Modern Ontology — V: Being and Essence” 18–20 June 2012, Saint-Petersburg, Russia
- Efficacy of Copper Metal on Probiotic Bacteria to Combat Dysbiosis
- Review of the International Conference “Human World: Normative Dimension” 13–15 June 2013, Saratov, Russia
- An Interaction Study of Metal Ions Complexation with Cephradine on Its Antibacterial Activity
- Review of the International Conference “Embodied Intersubjectivity: Between Phenomenological and Experimental Research” 3–4 June 2013, Prague, Czech Republic
Last modified: 2018-07-16 19:19:04